DK3385267T3 - Syntese af boronestere og syreforbindelser - Google Patents

Syntese af boronestere og syreforbindelser Download PDF

Info

Publication number: DK3385267T3
Authority: DK; Denmark
Prior art keywords: boronesteres; synthesis; acid compounds; compounds; acid
Prior art date: 2004-03-30

Application number

DK18172486.5T

Other languages

English (en)

Inventor

Fraser I Pickersgill

Young Lo

Fang-Ting Chui

Vithalanand R Kulkarni

John Bishop

Original Assignee

Millennium Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-30

Filing date

2005-03-24

Publication date

2021-11-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3385267(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-24 Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc

2021-11-01 Application granted granted Critical

2021-11-01 Publication of DK3385267T3 publication Critical patent/DK3385267T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Virology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Oncology (AREA)
Transplantation (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Catalysts (AREA)

DK18172486.5T 2004-03-30 2005-03-24 Syntese af boronestere og syreforbindelser DK3385267T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55753504P	2004-03-30	2004-03-30
EP11167263A EP2377868A1 (en)	2004-03-30	2005-03-24	Synthesis of Bortezomib

Publications (1)

Publication Number	Publication Date
DK3385267T3 true DK3385267T3 (da)	2021-11-01

Family

ID=34968044

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
DK05742865.8T DK1756121T3 (da)	2004-03-30	2005-03-24	Syntese af borester- og borsyreforbindelser
DK18172486.5T DK3385267T3 (da)	2004-03-30	2005-03-24	Syntese af boronestere og syreforbindelser
DK11167264.8T DK2377869T3 (da)	2004-03-30	2005-03-24	Syntese af Bortezomib
DK21197526.3T DK4008721T3 (da)	2004-03-30	2005-03-24	Syntese af boronester og syre forbindelser

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05742865.8T DK1756121T3 (da)	2004-03-30	2005-03-24	Syntese af borester- og borsyreforbindelser

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK11167264.8T DK2377869T3 (da)	2004-03-30	2005-03-24	Syntese af Bortezomib
DK21197526.3T DK4008721T3 (da)	2004-03-30	2005-03-24	Syntese af boronester og syre forbindelser

Country Status (41)

Country	Link
US (14)	US7714159B2 (da)
EP (5)	EP2377868A1 (da)
JP (4)	JP4558039B2 (da)
KR (1)	KR100939598B1 (da)
CN (5)	CN1960996B (da)
AR (3)	AR049374A1 (da)
AT (1)	ATE521612T1 (da)
AU (1)	AU2005230930B2 (da)
BR (1)	BRPI0509587A (da)
CA (4)	CA2560886C (da)
CL (2)	CL2010000350A1 (da)
CR (1)	CR8653A (da)
CY (3)	CY1112053T1 (da)
DK (4)	DK1756121T3 (da)
DO (1)	DOP2011000293A (da)
EA (1)	EA012927B1 (da)
EC (1)	ECSP066960A (da)
ES (4)	ES2974758T3 (da)
FI (1)	FI4008721T3 (da)
HK (1)	HK1246300A1 (da)
HR (4)	HRP20110846T1 (da)
HU (2)	HUE056859T2 (da)
IL (3)	IL178250A (da)
LT (2)	LT3385267T (da)
ME (1)	ME01975B (da)
MX (1)	MX367324B (da)
MY (1)	MY145427A (da)
NL (3)	NL1028639C2 (da)
NO (4)	NO338905B1 (da)
NZ (3)	NZ586824A (da)
PE (3)	PE20142402A1 (da)
PL (4)	PL4008721T3 (da)
PT (4)	PT1756121E (da)
RS (4)	RS51983B (da)
SG (5)	SG151322A1 (da)
SI (4)	SI3385267T1 (da)
TW (1)	TWI386212B (da)
UA (1)	UA90108C2 (da)
UY (3)	UY28830A1 (da)
WO (1)	WO2005097809A2 (da)
ZA (1)	ZA200608689B (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
PL4008721T3 (pl) *	2004-03-30	2024-05-13	Millennium Pharmaceuticals, Inc.	Synteza związków estrów i kwasów boronowych
WO2008075376A1 (en) *	2006-12-18	2008-06-26	Natco Pharma Limited	Polymorphic forms of bortezomib and process for their preparation
WO2009004350A1 (en) *	2007-07-03	2009-01-08	Pliva Hrvatska D.O.O.	Methods for preparing bortezomib and intermediates used in its manufacture
AU2016253697A1 (en) *	2007-08-06	2016-11-24	Millennium Pharmaceuticals, Inc.	Proteasome inhibitors
EA034601B1 (ru) *	2007-08-06	2020-02-25	Милленниум Фармасьютикалз, Инк.	Способ получения бороновых кислот
GEP20125599B (en) *	2007-08-06	2012-08-10	Millennium Pharm Inc	Proteasome inhibitors
US7442830B1 (en)	2007-08-06	2008-10-28	Millenium Pharmaceuticals, Inc.	Proteasome inhibitors
WO2009026579A1 (en) *	2007-08-23	2009-02-26	Cornell Research Foundation, Inc.	Proteasome inhibitors and their use in treating pathogen infection and cancer
MX2010002836A (es) *	2007-09-12	2010-03-31	Reddys Lab Ltd Dr	Bortezomib y proceso para la produccion del mismo.
US7838673B2 (en)	2007-10-16	2010-11-23	Millennium Pharmaceuticals, Inc.	Proteasome inhibitors
BR122014008753A2 (pt) *	2008-06-17	2015-12-29	Millennium Pharm Inc	compostos de éster boronato e composições farmacêuticas dos mesmos
AU2013204896A1 (en) *	2008-09-29	2013-05-16	Millennium Pharmaceuticals, Inc.	Derivatives of 1-amino-2-cyclobutylethylboronic acid
AR075090A1 (es)	2008-09-29	2011-03-09	Millennium Pharm Inc	Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
EP2238973A1 (en)	2009-04-07	2010-10-13	Cephalon France	Lyophilized preparations of proteasome inhibitors
CN101899062B (zh) *	2009-05-26	2015-04-15	上海威智医药科技有限公司	α-手性硼酸及硼酸酯的合成工艺
EP2280016A1 (en)	2009-07-27	2011-02-02	LEK Pharmaceuticals d.d.	New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
EP2270019A1 (en)	2009-06-19	2011-01-05	LEK Pharmaceuticals d.d.	New synthetic route for the preparation of alpha-amino boronic esters
US8785674B2 (en)	2009-06-19	2014-07-22	Lek Pharmaceuticals D.D.	Process for hydrogenation of halogenoalkenes without dehalogenation
CN102725300B (zh)	2009-12-22	2015-03-11	赛福伦公司	蛋白酶体抑制剂及其制备、纯化、和应用的方法
WO2011090940A1 (en)	2010-01-19	2011-07-28	Cerulean Pharma Inc.	Cyclodextrin-based polymers for therapeutic delivery
CA2789400A1 (en)	2010-02-09	2011-08-18	Ranbaxy Laboratories Limited	Process for the preparation of bortezomib
CN101781326B (zh) *	2010-02-11	2013-08-21	福建南方制药股份有限公司	一种制备手性氨基硼酸的中间体及其制备方法
WO2011107912A1 (en)	2010-03-04	2011-09-09	Ranbaxy Laboratories Limited	Polymorphic forms of bortezomib
US8263578B2 (en)	2010-03-18	2012-09-11	Innopharma, Inc.	Stable bortezomib formulations
RU2529800C2 (ru) *	2010-03-18	2014-09-27	ИННОФАРМА, Инк.	Стабильные составы бортезомиба
CN106008570A (zh)	2010-03-31	2016-10-12	米伦纽姆医药公司	1-氨基-2-环丙基乙硼酸衍生物
CN101812026B (zh) *	2010-04-12	2013-08-28	亚邦医药股份有限公司	一种硼替佐米的合成方法
WO2011146638A1 (en)	2010-05-18	2011-11-24	Cerulean Pharma Inc.	Compositions and methods for treatment of autoimmune and other diseases
WO2012048745A1 (en)	2010-10-14	2012-04-19	Synthon Bv	Process for making bortezomib and intermediates for the process
TW201309303A (zh)	2011-03-03	2013-03-01	Cephalon Inc	用於治療狼瘡的蛋白酶體抑制劑
CN102206188B (zh) *	2011-04-08	2013-02-27	苏州二叶制药有限公司	N-(吡嗪-2-基羰基)-l-苯丙氨酸的制备方法
US8497374B2 (en)	2011-05-12	2013-07-30	Scinopharm Taiwan, Ltd.	Process for preparing and purifying bortezomib
CN102268029B (zh) *	2011-05-19	2013-10-09	苏州二叶制药有限公司	化合物（1s,2s,3r,5s）-蒎烷二醇-l-苯丙氨酸-l-亮氨酸硼酸酯的制备
MX2013015308A (es)	2011-06-22	2014-05-20	Cephalon Inc	Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
CN102351890B (zh) *	2011-09-30	2014-07-02	重庆泰濠制药有限公司	一种硼替佐米的合成方法
CN102492021B (zh) *	2011-12-13	2013-10-23	重庆泰濠制药有限公司	硼替佐米的制备工艺
SG10201605152SA (en) *	2011-12-22	2016-08-30	Ares Trading Sa	Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
CN103374026A (zh) *	2012-04-27	2013-10-30	重庆医药工业研究院有限责任公司	一种硼替佐米中间体的制备方法
CN103450331B (zh) *	2012-06-05	2016-05-25	山东新时代药业有限公司	一种硼替佐米的精制方法
BR112015005343A2 (pt)	2012-09-11	2017-07-04	Cipla Ltd	processo para a preparação de bortezomib, composto, bortezomib ou seu anidrido, e, processo para a preparação de um composto
WO2014072985A1 (en)	2012-11-06	2014-05-15	Natco Pharma Limited	Novel boronic acid derivatives as anti cancer agents
JP2015536342A (ja)	2012-11-16	2015-12-21	シルパ・メディケア・リミテッドＳｈｉｌｐａＭｅｄｉｃａｒｅＬｉｍｉｔｅｄ	結晶ボルテゾミブの方法
JP6403219B2 (ja)	2012-12-07	2018-10-10	ベナトルクスファーマシューティカルズ，インク．	ベータ−ラクタマーゼ阻害剤
CN103897027A (zh) *	2012-12-29	2014-07-02	曹亚英	关键中间体晶型，制备方法及其在硼替佐米合成中的运用
CN103897026A (zh) *	2012-12-29	2014-07-02	朱继东	硼替佐米关键中间体的晶型，制备方法及其运用
EP2943204B1 (en)	2013-01-10	2019-03-13	Venatorx Pharmaceuticals Inc	Beta-lactamase inhibitors
EP2986619A1 (en)	2013-04-16	2016-02-24	Cipla Limited	Process for the preparation of bortezomib mannitol ester
CN104211758B (zh) *	2013-05-29	2020-06-12	深圳翰宇药业股份有限公司	一种硼替佐米的制备方法
CN103497233B (zh) *	2013-09-30	2015-04-08	哈药集团技术中心	一种硼替佐米的制备方法
CN103554219A (zh) *	2013-10-01	2014-02-05	昆明贵研药业有限公司	一种制备硼替佐米的方法
KR101691353B1 (ko) *	2013-12-09	2016-12-30	주식회사 경보제약	보르테조밉의 제조방법 및 그의 신규 중간체
EP3102585B1 (en)	2014-02-03	2021-05-19	Ohio State Innovation Foundation	Boronic acid esters and pharmaceutical formulations thereof
CN106659761A (zh)	2014-05-20	2017-05-10	千年药物公司	初级癌症疗法后使用的含硼蛋白酶体抑制剂
KR20220065084A (ko)	2014-06-11	2022-05-19	베나토알엑스 파마슈티컬스, 인크.	베타-락타마제 억제제
JP6420629B2 (ja) *	2014-10-30	2018-11-07	ボーグワーナーインコーポレーテッド	チェーンガイドおよびチェーンテンショナアーム
DE102015204151A1 (de) *	2015-03-09	2016-09-15	Adidas Ag	Ball, insbesondere Fußball, und Verfahren zur Herstellung eines Balls
JP6223508B2 (ja) *	2016-06-27	2017-11-01	ミレニアムファーマシューティカルズ，インコーポレイテッドＭｉｌｌｅｎｎｉｕｍＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	プロテアソーム阻害剤
EP3494121B1 (en)	2016-08-04	2021-10-06	Venatorx Pharmaceuticals, Inc.	Boron-containing compounds
US11667654B2 (en)	2017-02-17	2023-06-06	Fresenius Kabi Oncology Ltd.	Process for the preparation of boronic acid esters
SG11201908181XA (en)	2017-03-06	2019-10-30	Venatorx Pharmaceuticals Inc	Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
WO2018218154A1 (en)	2017-05-26	2018-11-29	VenatoRx Pharmaceuticals, Inc.	Penicillin-binding protein inhibitors
WO2018218190A1 (en)	2017-05-26	2018-11-29	VenatoRx Pharmaceuticals, Inc.	Penicillin-binding protein inhibitors
US11414437B2 (en)	2017-07-28	2022-08-16	Chengdu Origin Biotechnology Limited Company	Borate compound, and synthesis method therefor and uses thereof
US10927133B2 (en) *	2017-09-02	2021-02-23	Sun Pharmaceutical Industries Limited	Process for the preparation of ixazomib citrate
US12173018B2 (en)	2018-05-25	2024-12-24	VenatoRx Pharmaceuticals, Inc.	Penicillin-binding protein inhibitors
CN111187336B (zh) *	2018-11-14	2022-05-20	正大天晴药业集团股份有限公司	硼替佐米的精制方法
US11964993B2 (en)	2021-07-03	2024-04-23	Shilpa Pharma Lifesciences Limited	Crystalline bortezomib process
WO2025034812A2 (en)	2023-08-07	2025-02-13	Tae Life Sciences Llc	Trifluoroborate (bf3) compositions for use in boron neutron capture therapy and methods thereof
WO2025080942A1 (en) *	2023-10-13	2025-04-17	The Brigham And Women’S Hospital, Inc.	Proteasome inhibitors and methods of use thereof
CN120248757A (zh) *	2025-05-28	2025-07-04	滁州瑞达新能源材料有限公司	一种自清洁耐候的铝合金光伏组件边框及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL31992A (en) *	1968-05-08	1973-07-30	American Cyanamid Co	Synthetic thyrocalcitonins and method of making them
ZA794723B (en) *	1978-09-11	1980-08-27	Univ Miami	Anti-hypertensive agents
US4525309A (en) *	1983-03-15	1985-06-25	Washington State University Research Foundation, Inc.	Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents
US4537773A (en)	1983-12-05	1985-08-27	E. I. Du Pont De Nemours And Company	α-Aminoboronic acid derivatives
US4499082A (en)	1983-12-05	1985-02-12	E. I. Du Pont De Nemours And Company	α-Aminoboronic acid peptides
ES8603405A1 (es) *	1985-04-22	1985-12-16	Inke Sa	"procedimiento para la obtencion del ester benzilico de 1-(n-(1--etoxicarbonil-3-oxo-fenilpropil)-l-alanil)-l-prolina".
SE8506094D0 (sv) *	1985-12-20	1985-12-20	Astra Laekemedel Ab	New antibacterial agents and intermediates therefor
US4701545A (en) *	1986-02-12	1987-10-20	Washington State University Research Foundation, Inc.	Preparation of α,α-dihaloalkyl boronic esters
US5250720A (en)	1987-06-05	1993-10-05	The Dupont Merck Pharmaceutical Company	Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en)	1987-06-05	1993-09-07	The Dupont Merck Pharmaceutical Company	Peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en)	1987-06-05	1993-02-16	Du Pont Merck Pharmaceutical Company	Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) *	1987-11-05	1990-08-22	Hoechst Aktiengesellschaft	Renin-Inhibitoren
US5106948A (en)	1988-05-27	1992-04-21	Mao Foundation For Medical Education And Research	Cytotoxic boronic acid peptide analogs
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
EP2251344B2 (en) *	2001-01-25	2024-04-24	THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Formulation of boronic acid compounds
JPWO2003033507A1 (ja) *	2001-10-12	2005-02-03	杏林製薬株式会社	ベンジルマロン酸誘導体およびそれを含有するプロテアソーム阻害薬
JPWO2003033506A1 (ja) *	2001-10-12	2005-02-03	杏林製薬株式会社	アミノボラン酸誘導体およびそれを含有するプロテアソーム阻害薬
PL4008721T3 (pl)	2004-03-30	2024-05-13	Millennium Pharmaceuticals, Inc.	Synteza związków estrów i kwasów boronowych
WO2009004350A1 (en) *	2007-07-03	2009-01-08	Pliva Hrvatska D.O.O.	Methods for preparing bortezomib and intermediates used in its manufacture
US7838673B2 (en) *	2007-10-16	2010-11-23	Millennium Pharmaceuticals, Inc.	Proteasome inhibitors
US8785674B2 (en) *	2009-06-19	2014-07-22	Lek Pharmaceuticals D.D.	Process for hydrogenation of halogenoalkenes without dehalogenation

2005
- 2005-03-24 PL PL21197526.3T patent/PL4008721T3/pl unknown
- 2005-03-24 NZ NZ586824A patent/NZ586824A/en not_active IP Right Cessation
- 2005-03-24 LT LTEP18172486.5T patent/LT3385267T/lt unknown
- 2005-03-24 ES ES21197526T patent/ES2974758T3/es not_active Expired - Lifetime
- 2005-03-24 CA CA2560886A patent/CA2560886C/en not_active Expired - Lifetime
- 2005-03-24 MX MX2014005871A patent/MX367324B/es unknown
- 2005-03-24 JP JP2007506261A patent/JP4558039B2/ja not_active Expired - Lifetime
- 2005-03-24 EA EA200601795A patent/EA012927B1/ru unknown
- 2005-03-24 EP EP11167263A patent/EP2377868A1/en not_active Ceased
- 2005-03-24 SG SG200902156-9A patent/SG151322A1/en unknown
- 2005-03-24 NZ NZ550522A patent/NZ550522A/en not_active IP Right Cessation
- 2005-03-24 PT PT05742865T patent/PT1756121E/pt unknown
- 2005-03-24 DK DK05742865.8T patent/DK1756121T3/da active
- 2005-03-24 FI FIEP21197526.3T patent/FI4008721T3/fi active
- 2005-03-24 MY MYPI20051304A patent/MY145427A/en unknown
- 2005-03-24 SG SG10201600029PA patent/SG10201600029PA/en unknown
- 2005-03-24 DK DK18172486.5T patent/DK3385267T3/da active
- 2005-03-24 PT PT181724865T patent/PT3385267T/pt unknown
- 2005-03-24 CN CN200580017645.5A patent/CN1960996B/zh not_active Expired - Lifetime
- 2005-03-24 SG SG10201800972PA patent/SG10201800972PA/en unknown
- 2005-03-24 US US11/088,667 patent/US7714159B2/en active Active
- 2005-03-24 UA UAA200611339A patent/UA90108C2/uk unknown
- 2005-03-24 HR HR20110846T patent/HRP20110846T1/hr unknown
- 2005-03-24 SI SI200532297T patent/SI3385267T1/sl unknown
- 2005-03-24 CN CN201710810795.6A patent/CN107474062A/zh active Pending
- 2005-03-24 DK DK11167264.8T patent/DK2377869T3/da active
- 2005-03-24 EP EP18172486.5A patent/EP3385267B1/en not_active Expired - Lifetime
- 2005-03-24 KR KR1020067022780A patent/KR100939598B1/ko not_active Expired - Lifetime
- 2005-03-24 ES ES05742865T patent/ES2371652T3/es not_active Expired - Lifetime
- 2005-03-24 CN CN202010514035.2A patent/CN111925385B/zh not_active Expired - Lifetime
- 2005-03-24 RS RS20110502A patent/RS51983B/sr unknown
- 2005-03-24 PL PL18172486T patent/PL3385267T3/pl unknown
- 2005-03-24 PT PT111672648T patent/PT2377869E/pt unknown
- 2005-03-24 PL PL11167264T patent/PL2377869T3/pl unknown
- 2005-03-24 ES ES18172486T patent/ES2899606T3/es not_active Expired - Lifetime
- 2005-03-24 CN CN201310294873.3A patent/CN103396427B/zh not_active Expired - Lifetime
- 2005-03-24 ES ES11167264.8T patent/ES2457593T3/es not_active Expired - Lifetime
- 2005-03-24 SI SI200531843T patent/SI2377869T1/sl unknown
- 2005-03-24 SG SG2012049763A patent/SG182999A1/en unknown
- 2005-03-24 BR BRPI0509587-5A patent/BRPI0509587A/pt not_active Application Discontinuation
- 2005-03-24 RS RS20211565A patent/RS62738B1/sr unknown
- 2005-03-24 RS RS20240260A patent/RS65253B1/sr unknown
- 2005-03-24 SI SI200531401T patent/SI1756121T1/sl unknown
- 2005-03-24 AT AT05742865T patent/ATE521612T1/de active
- 2005-03-24 PL PL05742865T patent/PL1756121T3/pl unknown
- 2005-03-24 HR HRP20240307TT patent/HRP20240307T3/hr unknown
- 2005-03-24 NZ NZ598172A patent/NZ598172A/xx not_active IP Right Cessation
- 2005-03-24 LT LTEP21197526.3T patent/LT4008721T/lt unknown
- 2005-03-24 EP EP21197526.3A patent/EP4008721B1/en not_active Expired - Lifetime
- 2005-03-24 CA CA2738706A patent/CA2738706C/en not_active Expired - Lifetime
- 2005-03-24 RS RS20140186A patent/RS53259B/sr unknown
- 2005-03-24 SI SI200532318T patent/SI4008721T1/sl unknown
- 2005-03-24 HU HUE18172486A patent/HUE056859T2/hu unknown
- 2005-03-24 CA CA2853272A patent/CA2853272A1/en not_active Abandoned
- 2005-03-24 DK DK21197526.3T patent/DK4008721T3/da active
- 2005-03-24 WO PCT/US2005/009774 patent/WO2005097809A2/en not_active Ceased
- 2005-03-24 HU HUE21197526A patent/HUE065769T2/hu unknown
- 2005-03-24 EP EP05742865A patent/EP1756121B1/en not_active Expired - Lifetime
- 2005-03-24 EP EP11167264.8A patent/EP2377869B1/en not_active Expired - Lifetime
- 2005-03-24 SG SG2012049755A patent/SG182998A1/en unknown
- 2005-03-24 CN CN201810192292.1A patent/CN108329337B/zh not_active Expired - Lifetime
- 2005-03-24 ME MEP-2011-502A patent/ME01975B/me unknown
- 2005-03-24 HR HRP20212002TT patent/HRP20212002T1/hr unknown
- 2005-03-24 AU AU2005230930A patent/AU2005230930B2/en not_active Expired
- 2005-03-24 CA CA2859119A patent/CA2859119A1/en not_active Abandoned
- 2005-03-24 PT PT211975263T patent/PT4008721T/pt unknown
- 2005-03-29 NL NL1028639A patent/NL1028639C2/nl not_active IP Right Cessation
- 2005-03-29 PE PE2014001477A patent/PE20142402A1/es not_active Application Discontinuation
- 2005-03-29 TW TW094109818A patent/TWI386212B/zh not_active IP Right Cessation
- 2005-03-29 PE PE2009001314A patent/PE20110075A1/es active IP Right Grant
- 2005-03-29 PE PE2005000359A patent/PE20060162A1/es not_active Application Discontinuation
- 2005-03-30 AR ARP050101205A patent/AR049374A1/es active IP Right Grant
- 2005-03-30 UY UY28830A patent/UY28830A1/es active IP Right Grant
2006
- 2006-09-21 IL IL178250A patent/IL178250A/en active IP Right Grant
- 2006-09-22 CR CR8653A patent/CR8653A/es unknown
- 2006-10-18 ZA ZA200608689A patent/ZA200608689B/en unknown
- 2006-10-26 NO NO20064893A patent/NO338905B1/no unknown
- 2006-10-27 EC EC2006006960A patent/ECSP066960A/es unknown
2007
- 2007-01-08 NL NL1033190A patent/NL1033190C2/nl not_active IP Right Cessation
- 2007-01-08 NL NL1033189A patent/NL1033189C2/nl not_active IP Right Cessation
2010
- 2010-02-16 US US12/706,063 patent/US8283467B2/en not_active Expired - Lifetime
- 2010-04-09 CL CL2010000350A patent/CL2010000350A1/es unknown
- 2010-06-01 JP JP2010126333A patent/JP5414625B2/ja not_active Expired - Lifetime
2011
- 2011-09-23 DO DO2011000293A patent/DOP2011000293A/es unknown
- 2011-11-21 CY CY20111101122T patent/CY1112053T1/el unknown
2012
- 2012-05-17 IL IL219856A patent/IL219856A/en active IP Right Grant
- 2012-05-17 IL IL219853A patent/IL219853A/en active IP Right Grant
- 2012-09-14 US US13/615,894 patent/US20130005968A1/en not_active Abandoned
2013
- 2013-03-06 JP JP2013043972A patent/JP5894952B2/ja not_active Expired - Lifetime
- 2013-08-07 UY UY34969A patent/UY34969A/es not_active Application Discontinuation
2014
- 2014-03-06 US US14/199,265 patent/US20150038706A1/en not_active Abandoned
- 2014-04-08 HR HRP20140339TT patent/HRP20140339T1/hr unknown
- 2014-04-17 CY CY20141100297T patent/CY1115336T1/el unknown
- 2014-05-19 UY UY0001035578A patent/UY35578A/es not_active Application Discontinuation
- 2014-08-11 AR ARP140103012A patent/AR097309A2/es active IP Right Grant
- 2014-08-11 AR ARP140103013A patent/AR097310A2/es unknown
- 2014-08-25 CL CL2014002252A patent/CL2014002252A1/es unknown
2015
- 2015-11-30 JP JP2015232705A patent/JP6193960B2/ja not_active Expired - Lifetime
2016
- 2016-01-08 US US14/991,363 patent/US9862745B2/en not_active Expired - Lifetime
- 2016-08-24 NO NO20161350A patent/NO344610B1/no unknown
2017
- 2017-09-22 US US15/713,005 patent/US10000529B2/en not_active Expired - Lifetime
- 2017-12-05 NO NO20171939A patent/NO343966B1/no unknown
2018
- 2018-05-03 HK HK18105728.8A patent/HK1246300A1/zh unknown
- 2018-05-23 US US15/986,972 patent/US20180265546A1/en not_active Abandoned
- 2018-12-13 US US16/218,783 patent/US20190112334A1/en not_active Abandoned
2019
- 2019-07-11 US US16/508,706 patent/US20190330270A1/en not_active Abandoned
- 2019-09-04 NO NO20191065A patent/NO20191065A1/no not_active Application Discontinuation
2020
- 2020-01-24 US US16/751,374 patent/US20200157143A1/en not_active Abandoned
- 2020-08-13 US US16/992,353 patent/US20200369722A1/en not_active Abandoned
2021
- 2021-02-19 US US17/179,508 patent/US20210171574A1/en not_active Abandoned
- 2021-09-02 US US17/465,144 patent/US20210395301A1/en not_active Abandoned
- 2021-11-24 CY CY20211101021T patent/CY1124753T1/el unknown
2022
- 2022-03-14 US US17/694,545 patent/US20220204558A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BRPI0509587A (pt)	2007-09-25
DK2377869T3 (da)	2014-04-14
EP4008721A1 (en)	2022-06-08
IL219856A0 (en)	2012-06-28
CA2859119A1 (en)	2005-10-20
ES2457593T3 (es)	2014-04-28
US10000529B2 (en)	2018-06-19
CN108329337B (zh)	2021-06-25
PE20142402A1 (es)	2015-02-04
EP2377869A1 (en)	2011-10-19
JP5414625B2 (ja)	2014-02-12
CN1960996A (zh)	2007-05-09
CY1124753T1 (el)	2022-07-22
LT3385267T (lt)	2021-11-10
US20160362449A1 (en)	2016-12-15
AR097309A2 (es)	2016-03-02
US20210395301A1 (en)	2021-12-23
ES2974758T3 (es)	2024-07-01
CA2853272A1 (en)	2005-10-20
CN103396427A (zh)	2013-11-20
TWI386212B (zh)	2013-02-21
AU2005230930B2 (en)	2011-09-29
EP4008721B1 (en)	2024-01-03
US9862745B2 (en)	2018-01-09
PT3385267T (pt)	2021-11-23
LT4008721T (lt)	2024-03-25
NO20171939A1 (no)	2006-12-22
HRP20110846T1 (hr)	2011-12-31
CA2738706C (en)	2014-10-14
SG182998A1 (en)	2012-08-30
CR8653A (es)	2007-10-23
IL178250A (en)	2012-06-28
HK1100004A1 (en)	2007-08-31
PT2377869E (pt)	2014-04-15
SI1756121T1 (sl)	2012-03-30
EP3385267A1 (en)	2018-10-10
US20100174072A1 (en)	2010-07-08
HRP20212002T1 (hr)	2022-04-01
US20190112334A1 (en)	2019-04-18
NL1028639A1 (nl)	2005-10-20
NO20191065A1 (no)	2006-12-22
SI2377869T1 (sl)	2014-05-30
PT4008721T (pt)	2024-03-21
NL1033190C2 (nl)	2007-11-27
PL4008721T3 (pl)	2024-05-13
IL178250A0 (en)	2006-12-31
EP1756121A2 (en)	2007-02-28
CA2560886A1 (en)	2005-10-20
SI4008721T1 (sl)	2024-05-31
DK1756121T3 (da)	2012-01-09
JP2007530687A (ja)	2007-11-01
HRP20240307T3 (hr)	2024-05-10
EP2377869B1 (en)	2014-01-29
NL1028639C2 (nl)	2007-01-17
RS51983B (sr)	2012-02-29
US20130005968A1 (en)	2013-01-03
UA90108C2 (uk)	2010-04-12
JP2016056180A (ja)	2016-04-21
CL2014002252A1 (es)	2014-12-05
JP5894952B2 (ja)	2016-03-30
PL2377869T3 (pl)	2014-07-31
PL3385267T3 (pl)	2022-02-14
AR049374A1 (es)	2006-07-26
CA2738706A1 (en)	2005-10-20
AU2005230930A1 (en)	2005-10-20
ZA200608689B (en)	2007-09-26
RS65253B1 (sr)	2024-03-29
HUE065769T2 (hu)	2024-06-28
SG10201800972PA (en)	2018-03-28
NO338905B1 (no)	2016-10-31
US20220204558A1 (en)	2022-06-30
NO20064893L (no)	2006-12-22
NZ598172A (en)	2013-08-30
HK1257298A1 (zh)	2019-10-18
ECSP066960A (es)	2006-12-20
MY145427A (en)	2012-02-15
IL219856A (en)	2015-05-31
US8283467B2 (en)	2012-10-09
WO2005097809A2 (en)	2005-10-20
NZ586824A (en)	2012-03-30
PL1756121T3 (pl)	2012-02-29
EA200601795A1 (ru)	2007-04-27
CY1115336T1 (el)	2017-01-04
WO2005097809A3 (en)	2006-02-16
EP3385267B1 (en)	2021-09-29
RS53259B (sr)	2014-08-29
JP6193960B2 (ja)	2017-09-06
NO343966B1 (no)	2019-07-29
CN111925385A (zh)	2020-11-13
TW200616646A (en)	2006-06-01
ATE521612T1 (de)	2011-09-15
KR20070007873A (ko)	2007-01-16
SG151322A1 (en)	2009-04-30
HUE056859T2 (hu)	2022-03-28
AR097310A2 (es)	2016-03-02
SI3385267T1 (sl)	2022-04-29
UY34969A (es)	2015-02-27
CN103396427B (zh)	2018-04-13
US20190330270A1 (en)	2019-10-31
HK1246300A1 (zh)	2018-09-07
NL1033189A1 (nl)	2007-10-22
FI4008721T3 (fi)	2024-03-19
US20200157143A1 (en)	2020-05-21
CN1960996B (zh)	2016-04-20
US20180044377A1 (en)	2018-02-15
US7714159B2 (en)	2010-05-11
ME01975B (me)	2015-05-20
NL1033190A1 (nl)	2007-04-23
JP4558039B2 (ja)	2010-10-06
ES2899606T3 (es)	2022-03-14
EP2377868A1 (en)	2011-10-19
EA012927B1 (ru)	2010-02-26
ES2371652T3 (es)	2012-01-05
NO344610B1 (no)	2020-02-10
SG10201600029PA (en)	2016-02-26
RS62738B1 (sr)	2022-01-31
HK1164320A1 (en)	2012-10-19
CL2010000350A1 (es)	2011-01-28
KR100939598B1 (ko)	2010-02-01
CA2560886C (en)	2014-08-12
CN111925385B (zh)	2023-11-21
CY1112053T1 (el)	2015-11-04
MX367324B (es)	2019-08-15
NO20161350A1 (no)	2006-12-22
PE20110075A1 (es)	2011-02-17
IL219853A0 (en)	2012-06-28
US20050240047A1 (en)	2005-10-27
US20180265546A1 (en)	2018-09-20
EP1756121B1 (en)	2011-08-24
HRP20140339T1 (hr)	2014-05-09
SG182999A1 (en)	2012-08-30
UY28830A1 (es)	2005-09-30
CN107474062A (zh)	2017-12-15
UY35578A (es)	2016-01-08
DOP2011000293A (es)	2011-12-15
US20210171574A1 (en)	2021-06-10
JP2013100378A (ja)	2013-05-23
US20200369722A1 (en)	2020-11-26
PE20060162A1 (es)	2006-04-07
JP2010241816A (ja)	2010-10-28
NZ550522A (en)	2010-08-27
PT1756121E (pt)	2011-11-30
IL219853A (en)	2015-05-31
DK4008721T3 (da)	2024-03-25
US20150038706A1 (en)	2015-02-05
NL1033189C2 (nl)	2008-08-14
CN108329337A (zh)	2018-07-27

Publication	Publication Date	Title
DK3385267T3 (da)	2021-11-01	Syntese af boronestere og syreforbindelser
DK1778618T3 (da)	2014-03-10	Syntese af triethylentetraminer
CY2022001I2 (el)	2023-01-27	Παραγωγα του uk-2a
DK1831154T3 (da)	2010-04-12	Fremstilling af pregabalin og relaterede forbindelser
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DK1716115T3 (da)	2013-05-27	Syntese af acyloxyalkylcarbamat-prodrug og mellemprodukter deraf
DK2322517T3 (da)	2019-06-11	Fremgangsmåder til kemisk syntese og oprensning af diaminophenothiaziniumforbindelser med methylthioniniumchlorid (mtc)
DK1937824T3 (da)	2013-04-02	Sammensætninger af tRNA og anvendelser deraf
LTPA2017004I1 (lt)	2017-03-10	Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
DK1824475T3 (da)	2011-06-06	Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1658295T3 (da)	2007-09-24	Regioselektiv syntese af CCI-779
DK1667986T3 (da)	2013-05-06	Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1871738T3 (da)	2009-09-21	N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse
DK3121169T3 (da)	2022-02-28	Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
EP1771786A4 (en)	2011-05-25	SAMPLE PROCESSING SIMULTANEOUS
DK1720866T3 (da)	2011-11-21	Fremgangsmåde
PL1636190T3 (pl)	2012-10-31	Trwały kryształ związku 4-oksochinoliny
DK2402005T3 (da)	2021-03-15	Formuleringer med langvarig frigivelse af nalbuphin
NO20043305D0 (no)	2004-08-09	Preparation of lodixanol
DK2305689T3 (da)	2014-07-14	Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser
DK1730109T3 (da)	2008-09-29	Syntese af pyrrol-2-carbonitriler
DE602004031534D1 (de)	2011-04-07	Stabiler polymorph von bifeprunoxmesilat
FR2877833B1 (fr)	2007-10-12	Correcteur de lordoses
DK2301576T3 (da)	2012-12-10	Terapeutisk anvendelse af anti-CS1-antistoffer
DK1611083T3 (da)	2008-01-21	Syntese af 2-chlormethyl-6-methylbenzoesyreestere